Psychosis
- Editorial: The Endocannabinoid System: Filling the Translational Gap Between Neuroscience and Psychiatry (05 Sep 2022)
- The Expanded Endocannabinoid System Contributes to Metabolic and Body Mass Shifts in First-Episode Schizophrenia: A 5-Year Follow-Up Study (07 Aug 2022)
- The Autism–Psychosis Continuum Conundrum: Exploring the Role of the Endocannabinoid System (31 Jul 2022)
- Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders (31 Jul 2022)
- The use and effects of synthetic cannabinoid receptor agonists by New South Wales cannabis treatment clients - Journal of Cannabis Research (26 Jul 2022)
- The therapeutic role of Cannabidiol in mental health: a systematic review - Journal of Cannabis Research (26 Jul 2022)
- Staff awareness of the use of cannabidiol (CBD): a trust-wide survey study in the UK - Journal of Cannabis Research (26 Jul 2022)
- Medicinal cannabis: knowledge, beliefs, and attitudes of Colombian psychiatrists - Journal of Cannabis Research (26 Jul 2022)
- Pioneering clinical trial to treat psychosis in Parkinson's patients using cannabidiol (18 Jul 2022)
- New insight into how cannabidiol takes effect in the brains of people with psychosis (18 Jul 2022)
- Cannabis extract helps reset brain function in psychosis (18 Jul 2022)